SEARCH

SEARCH BY CITATION

Summary

Twenty-four patients with chronic urticaria resistant to conventional therapy were treated orally with terbutaline, a specific β2 stimulant. This therapy was much more effective than antihistamines. At the dose of 1.25 mg three times a day, there were few side effects. The efficacy was independent of the IgE levels; it seemed greater in idiopathic cases than in cholinergic or pressure induced urticaria.